FAM133B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.699200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.720600E-01
Normal-vs-Stage2
3.852600E-01
Normal-vs-Stage3
6.422200E-02
Normal-vs-Stage4
7.194800E-01
Stage1-vs-Stage2
6.225800E-01
Stage1-vs-Stage3
1.470570E-01
Stage1-vs-Stage4
9.443600E-01
Stage2-vs-Stage3
2.099200E-01
Stage2-vs-Stage4
6.225000E-01
Stage3-vs-Stage4
1.086190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.589600E-01
Normal-vs-AfricanAmerican
5.762800E-01
Normal-vs-Asian
4.538400E-01
Caucasian-vs-AfricanAmerican
8.300800E-01
Caucasian-vs-Asian
7.243800E-01
AfricanAmerican-vs-Asian
7.587000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.034800E-01
Normal-vs-Female
4.796000E-01
Male-vs-Female
2.781800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.716400E-01
Normal-vs-Age(41-60Yrs)
8.287800E-01
Normal-vs-Age(61-80Yrs)
2.350400E-01
Normal-vs-Age(81-100Yrs)
6.637900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.718200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.146600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.617900E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.630400E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.037600E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.764600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.324030E-01
Normal-vs-Daily Drinker
1.211220E-01
Normal-vs-Weekly Drinker
3.873200E-01
Normal-vs-Occasional Drinker
6.248800E-01
Normal-vs-Social Drinker
7.115800E-01
Non Drinker-vs-Daily Drinker
6.227600E-01
Non Drinker-vs-Weekly Drinker
4.955000E-01
Non Drinker-vs-Occasional Drinker
8.879900E-02
Non Drinker-vs-Social Drinker
9.201900E-02
Daily Drinker-vs-Weekly Drinker
3.342000E-01
Daily Drinker-vs-Occasional Drinker
5.939800E-02
Daily Drinker-vs-Social Drinker
6.713800E-02
Weekly Drinker-vs-Occasional Drinker
4.670400E-01
Weekly Drinker-vs-Social Drinker
4.443400E-01
Occasional Drinker-vs-Social Drinker
9.031400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.257800E-01
Normal-vs-Grade 2
2.551400E-01
Normal-vs-Grade 3
2.954400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.306000E-01
Grade 1-vs-Grade 3
8.291000E-01
Grade 1-vs-Grade 4
3.257800E-01
Grade 2-vs-Grade 3
9.187400E-01
Grade 2-vs-Grade 4
2.551400E-01
Grade 3-vs-Grade 4
2.954400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.063700E-02
Normal-vs-NonDiabetic
3.932800E-01
Diabetic-vs-NonDiabetic
2.504300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.526300E-02
Normal-vs-NoPancreatitis
3.385800E-01
Pancreatitis-vs-NoPancreatitis
1.913820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.252800E-01
Normal-vs-N1
3.968400E-01
N0-vs-N1
4.867000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.777600E-01
Normal-vs-TP53-NonMutant
9.246000E-01
TP53-Mutant-vs-TP53-NonMutant
3.115400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
